<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21697485</PMID><DateCompleted><Year>2011</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>85</Volume><Issue>17</Issue><PubDate><Year>2011</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3.</ArticleTitle><Pagination><StartPage>8811</StartPage><EndPage>8818</EndPage><MedlinePgn>8811-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.00447-11</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) causes hand-foot-and-mouth disease and neurological complications in young children. Although the underlying mechanisms remain obscure, impaired or aberrant immunity is thought to play a role. In infected cells, EV71 suppresses type I interferon responses mediated by retinoid acid-inducible gene I (RIG-I). This involves the EV71 3C protein, which disrupts the formation of a functional RIG-I complex. In the present study, we report that EV71 inhibits the induction of innate immunity by Toll-like receptor 3 (TLR3) via a distinct mechanism. In HeLa cells stimulated with poly(I &#xb7; C), EV71 inactivates interferon regulatory factor 3 and drastically suppresses interferon-stimulated gene expression. Notably, EV71 specifically downregulates a TRIF, TIR domain-containing adaptor inducing beta interferon (IFN-&#x3b2;). When expressed alone in mammalian cells, EV71 3C is capable of exhibiting these activities. EV71 3C associates with and induces TRIF cleavage in the presence of Z-VAD-FMK, a caspase inhibitor. TRIF cleavage depends on its amino acid pair Q312-S313, which resembles a proteolytic site of picornavirus 3C proteases. Further, site-specific 3C mutants with a defective protease activity bind TRIF but fail to mediate TRIF cleavage. Consequently, these 3C mutants are unable to inhibit NF-&#x3ba;B and IFN-&#x3b2; promoter activation. TRIF cleavage mediated by EV71 may be a mechanism to impair type I IFN production in response to Toll-like receptor 3 (TLR3) activation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Xiaobo</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Molecular Virology and Genetic Engineering, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Zhenmin</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xinlei</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Qi</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Bin</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jianwei</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 AI092230</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AI092230</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D033942">Adaptor Proteins, Vesicular Transport</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050505">Mutant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C470409">TICAM1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495344">TLR3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051196">Toll-Like Receptor 3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.28</RegistryNumber><NameOfSubstance UI="D000086042">3C Viral Proteases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086042" MajorTopicYN="N">3C Viral Proteases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033942" MajorTopicYN="N">Adaptor Proteins, Vesicular Transport</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="Y">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016297" MajorTopicYN="N">Mutagenesis, Site-Directed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050505" MajorTopicYN="N">Mutant Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025941" MajorTopicYN="N">Protein Interaction Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051196" MajorTopicYN="N">Toll-Like Receptor 3</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2012</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21697485</ArticleId><ArticleId IdType="pmc">PMC3165803</ArticleId><ArticleId IdType="doi">10.1128/JVI.00447-11</ArticleId><ArticleId IdType="pii">JVI.00447-11</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>AbuBakar S., et al. 1999. Identification of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease (HFMD) with fatal cases of encephalomyelitis in Malaysia. Virus Res. 61:1&#x2013;9</Citation><ArticleIdList><ArticleId IdType="pubmed">10426204</ArticleId></ArticleIdList></Reference><Reference><Citation>AbuBakar S., et al. 2009. Enterovirus 71 outbreak, Brunei. Emerg. Infect. Dis. 15:79&#x2013;82</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2660687</ArticleId><ArticleId IdType="pubmed">19116058</ArticleId></ArticleIdList></Reference><Reference><Citation>Barral P. M., et al. 2007. MDA-5 is cleaved in poliovirus-infected cells. J. Virol. 81:3677&#x2013;3684</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1866155</ArticleId><ArticleId IdType="pubmed">17267501</ArticleId></ArticleIdList></Reference><Reference><Citation>Barral P. M., Sarkar D., Fisher P. B., Racaniello V. R. 2009. RIG-I is cleaved during picornavirus infection. Virology 391:171&#x2013;176</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2743091</ArticleId><ArticleId IdType="pubmed">19628239</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L. Y., et al. 2007. Neurodevelopment and cognition in children after enterovirus 71 infection. N. Engl. J. Med. 356:1226&#x2013;1234</Citation><ArticleIdList><ArticleId IdType="pubmed">17377160</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y. C., et al. 2004. A murine oral enterovirus 71 infection model with central nervous system involvement. J. Gen. Virol. 85:69&#x2013;77</Citation><ArticleIdList><ArticleId IdType="pubmed">14718621</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Z. D., Cerveny M., Yan Z. P., He B. 2007. The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA dependent protein kinase PKR. J. Virol. 81:182&#x2013;192</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1797262</ArticleId><ArticleId IdType="pubmed">17065211</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald K. A., et al. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:491&#x2013;496</Citation><ArticleIdList><ArticleId IdType="pubmed">12692549</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert G. L., et al. 1988. Outbreak of enterovirus 71 infection in Victoria, Australia, with a high incidence of neurologic involvement. Pediatr. Infect. Dis. J. 7:484&#x2013;488</Citation><ArticleIdList><ArticleId IdType="pubmed">2841639</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitlin L., et al. 2006. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. U. S. A. 103:8459&#x2013;8464</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1464000</ArticleId><ArticleId IdType="pubmed">16714379</ArticleId></ArticleIdList></Reference><Reference><Citation>Hacker H., et al. 2006. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439:204&#x2013;207</Citation><ArticleIdList><ArticleId IdType="pubmed">16306937</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M., et al. 1999. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N. Engl. J. Med. 341:929&#x2013;935</Citation><ArticleIdList><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C. C., et al. 1999. Neurologic complications in children with enterovirus 71 infection N. Engl. J. Med. 341:936&#x2013;942</Citation><ArticleIdList><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Z., Mak T. W., Sen G., Li X. 2004. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta. Proc. Natl. Acad. Sci. U. S. A. 101:3533&#x2013;3538</Citation><ArticleIdList><ArticleId IdType="pmc">PMC373497</ArticleId><ArticleId IdType="pubmed">14982987</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Z., et al. 2003. Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFkappa B and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR. J. Biol. Chem. 278:16713&#x2013;16719</Citation><ArticleIdList><ArticleId IdType="pubmed">12609980</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato H., et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101&#x2013;105</Citation><ArticleIdList><ArticleId IdType="pubmed">16625202</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T., Akira S. 2006. Innate immune recognition of viral infection. Nat. Immunol. 7:131&#x2013;137</Citation><ArticleIdList><ArticleId IdType="pubmed">16424890</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T., et al. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6:981&#x2013;988</Citation><ArticleIdList><ArticleId IdType="pubmed">16127453</ArticleId></ArticleIdList></Reference><Reference><Citation>Kehle J., Roth B., Metzger C., Pfitzner A., Enders G. 2003. Molecular characterization of an enterovirus 71 causing neurological disease in Germany. J. Neurovirol. 9:126&#x2013;128</Citation><ArticleIdList><ArticleId IdType="pubmed">12587076</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong W. X., Foo D. G., Trasti S. L., Tan E. L., Alonso S. 2011. Sustained high levels of interleukin-6 contribute to the pathogenesis of enterovirus 71 in a neonate mouse model. J. Virol. 85:3067&#x2013;3076</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3067852</ArticleId><ArticleId IdType="pubmed">21228224</ArticleId></ArticleIdList></Reference><Reference><Citation>Kundu P., Raychaudhuri S., Tsai W., Dasgupta A. 2005. Shutoff of RNA polymerase II transcription by poliovirus involves 3C protease-mediated cleavage of the TATA-binding protein at an alternative site: incomplete shutoff of transcription interferes with efficient viral replication. J. Virol. 79:9702&#x2013;9713</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1181600</ArticleId><ArticleId IdType="pubmed">16014932</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X. B., et al. 2010. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation. J. Virol. 84:8051&#x2013;8061</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2916543</ArticleId><ArticleId IdType="pubmed">20519382</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K., et al. 2005. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. U. S. A. 102:2992&#x2013;2997</Citation><ArticleIdList><ArticleId IdType="pmc">PMC548795</ArticleId><ArticleId IdType="pubmed">15710891</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., et al. 2005. Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China. J. Clin. Microbiol. 43:3835&#x2013;3839</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1233905</ArticleId><ArticleId IdType="pubmed">16081920</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M. L., et al. 2002. The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology 293:386&#x2013;395</Citation><ArticleIdList><ArticleId IdType="pubmed">11886259</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y. W., et al. 2009. Lymphocyte and antibody responses reduce enterovirus 71 lethality in mice by decreasing tissue viral loads. J. Virol. 83:6477&#x2013;6483</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2698549</ArticleId><ArticleId IdType="pubmed">19386699</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M. L., et al. 2005. Type I interferons protect mice against enterovirus 71 infection. J. Gen. Virol. 86:3263&#x2013;3269</Citation><ArticleIdList><ArticleId IdType="pubmed">16298971</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P., Stratov I., Nagarajan L., Davis S. 2001. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin. Infect. Dis. 32:236&#x2013;242</Citation><ArticleIdList><ArticleId IdType="pubmed">11170913</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P. C. 2002. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 26:91&#x2013;107</Citation><ArticleIdList><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>McWhirter S. M., et al. 2004. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 101:233&#x2013;238</Citation><ArticleIdList><ArticleId IdType="pmc">PMC314168</ArticleId><ArticleId IdType="pubmed">14679297</ArticleId></ArticleIdList></Reference><Reference><Citation>Meylan E., et al. 2004. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat. Immunol. 5:503&#x2013;507</Citation><ArticleIdList><ArticleId IdType="pubmed">15064760</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee A., et al. 2011. The coxsackievirus B 3Cpro protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog. 7:e1001311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3059221</ArticleId><ArticleId IdType="pubmed">21436888</ArticleId></ArticleIdList></Reference><Reference><Citation>Negishi H., et al. 2008. A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proc. Natl. Acad. Sci. U. S. A. 105:20446&#x2013;20451</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2629334</ArticleId><ArticleId IdType="pubmed">19074283</ArticleId></ArticleIdList></Reference><Reference><Citation>Oganesyan G., et al. 2006. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439:208&#x2013;211</Citation><ArticleIdList><ArticleId IdType="pubmed">16306936</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshiumi H., Matsumoto M., Funami K., Akazawa T., Seya T. 2003. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat. Immunol. 4:161&#x2013;167</Citation><ArticleIdList><ArticleId IdType="pubmed">12539043</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallai P. V., et al. 1989. Cleavage of synthetic peptides by purified poliovirus 3C proteinase. J. Biol. Chem. 264:9738&#x2013;9741</Citation><ArticleIdList><ArticleId IdType="pubmed">2542331</ArticleId></ArticleIdList></Reference><Reference><Citation>Papon L., et al. 2009. The viral RNA recognition sensor RIG-I is degraded during encephalomyocarditis virus (EMCV) infection. Virology 393:311&#x2013;318</Citation><ArticleIdList><ArticleId IdType="pubmed">19733381</ArticleId></ArticleIdList></Reference><Reference><Citation>Parks G. D., Baker J. C., Palmenberg A. C. 1989. Proteolytic cleavage of encephalomyocarditis virus capsid region substrates by precursors to the 3C enzyme. J. Virol. 63:1054&#x2013;1058</Citation><ArticleIdList><ArticleId IdType="pmc">PMC247798</ArticleId><ArticleId IdType="pubmed">2536819</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters K. L., Smith H. L., Stark G. R., Sen G. C. 2002. IRF-3-dependent, NFkappa B- and JNK-independent activation of the 561 and IFN-beta genes in response to double-stranded RNA. Proc. Natl. Acad. Sci. U. S. A. 99:6322&#x2013;6327</Citation><ArticleIdList><ArticleId IdType="pmc">PMC122947</ArticleId><ArticleId IdType="pubmed">11972054</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebsamen M., Meylan E., Curran J., Tschopp J. 2008. The antiviral adaptor proteins Cardif and Trif are processed and inactivated by caspases. Cell Death Differ. 15:1804&#x2013;1811</Citation><ArticleIdList><ArticleId IdType="pubmed">18756281</ArticleId></ArticleIdList></Reference><Reference><Citation>Richer M. J., Lavall&#xe9;e D. J., Shanina I., Horwitz M. S. 2009. Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection. PLoS One 4:e4127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2606033</ArticleId><ArticleId IdType="pubmed">19122812</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan M. D., Flint M. 1997. Virus-encoded proteinases of the picornavirus super-group. J. Gen. Virol. 78:699&#x2013;723</Citation><ArticleIdList><ArticleId IdType="pubmed">9129643</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasai M., et al. 2005. NF-kB-activated kinase-associated protein 1 participates in TLR3/Toll-IL-1 homology domain-containing adapter molecule-1 mediated IFN regulatory factor 3 activation. J. Immunol. 174:27&#x2013;30</Citation><ArticleIdList><ArticleId IdType="pubmed">15611223</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S., tenOever B. R., Grandvaux N., Zhou G. P., Lin R., Hiscott J. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148&#x2013;1151</Citation><ArticleIdList><ArticleId IdType="pubmed">12702806</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih S. R., et al. 2004. Mutations at KFRDI and VGK domains of enterovirus 71 3C protease affect its RNA binding and proteolytic activities. J. Biomed. Sci. 11:239&#x2013;248</Citation><ArticleIdList><ArticleId IdType="pubmed">14966374</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim A. C., Luhur A., Tan T. M., Chow V. T., Poh C. L. 2005. RNA interference against enterovirus 71 infection. Virology 341:72&#x2013;79</Citation><ArticleIdList><ArticleId IdType="pubmed">16083932</ArticleId></ArticleIdList></Reference><Reference><Citation>Verpooten D., Ma Y., Hou S., Yan Z., He B. 2009. Control of TANK-binding kinase 1-mediated signaling by the gamma(1)34.5 protein of herpes simplex virus 1. J. Biol. Chem. 284:1097&#x2013;1105</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2613634</ArticleId><ArticleId IdType="pubmed">19010780</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., et al. 2009. Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses. J. Immunol. 183:6989&#x2013;6997</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2920602</ArticleId><ArticleId IdType="pubmed">19890046</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng K. F., Li M. L., Huang C. T., Shih S. R. 2009. Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Pathog. 5:e1000593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2742901</ArticleId><ArticleId IdType="pubmed">19779565</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto M., et al. 2003. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301:640&#x2013;643</Citation><ArticleIdList><ArticleId IdType="pubmed">12855817</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F., et al. 2009. Enterovirus 71 outbreak in the People's Republic of China in 2008. J. Clin. Microbiol. 47:2351&#x2013;2352</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2708525</ArticleId><ArticleId IdType="pubmed">19439545</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., et al. 2007. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc. Natl. Acad. Sci. U. S. A. 104:7253&#x2013;7258</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1855380</ArticleId><ArticleId IdType="pubmed">17438296</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoneyama M., et al. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730&#x2013;737</Citation><ArticleIdList><ArticleId IdType="pubmed">15208624</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>